Shanghai Rongtai Health Technology Corporation Limited (SHA:603579)
China · Delayed Price · Currency is CNY 24.95
+0.24 (0.97%)
At close: Feb 6, 2026
SHA:603579 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 1,559 | 1,575 | 1,845 | 1,986 | 2,586 | 1,998 |
Other Revenue | 21.91 | 21.91 | 9.87 | 18.58 | 27.06 | 22.56 |
| 1,581 | 1,597 | 1,855 | 2,005 | 2,613 | 2,021 | |
Revenue Growth (YoY) | -8.17% | -13.92% | -7.47% | -23.26% | 29.30% | -12.68% |
Cost of Revenue | 1,085 | 1,095 | 1,294 | 1,476 | 1,913 | 1,443 |
Gross Profit | 495.58 | 502.03 | 561.3 | 528.47 | 699.91 | 577.18 |
Selling, General & Admin | 289.59 | 266.32 | 277.87 | 280.34 | 329.02 | 249.99 |
Research & Development | 93.24 | 80.1 | 80.18 | 88.66 | 119.21 | 100.12 |
Other Operating Expenses | 1.14 | 6.62 | 7.7 | 7.83 | 6.27 | 5.24 |
Operating Expenses | 385.5 | 355.83 | 364.86 | 382.33 | 460.41 | 355.35 |
Operating Income | 110.08 | 146.2 | 196.44 | 146.14 | 239.5 | 221.83 |
Interest Expense | -23.37 | -5.9 | -27.41 | -28.79 | -28.74 | -6.84 |
Interest & Investment Income | 73.17 | 53.88 | 64.11 | 44.37 | 104.76 | 25.47 |
Currency Exchange Gain (Loss) | 7.42 | 7.42 | 7.9 | 25.76 | -15.75 | -29.61 |
Other Non Operating Income (Expenses) | 3.68 | 3.06 | -7.2 | -27.66 | -58.25 | -32.58 |
EBT Excluding Unusual Items | 170.98 | 204.66 | 233.84 | 159.82 | 241.52 | 178.26 |
Gain (Loss) on Sale of Investments | -1.53 | -6.14 | -16.22 | 10.41 | 4.69 | 7.05 |
Gain (Loss) on Sale of Assets | 2.4 | 0.7 | -0.95 | 0.15 | 1.31 | 2.88 |
Asset Writedown | -1.33 | -1.21 | -1.29 | -0.01 | -1.7 | -0.24 |
Other Unusual Items | 11.98 | 11.98 | 14.81 | 9 | 15.13 | 10.22 |
Pretax Income | 182.5 | 209.99 | 230.19 | 179.37 | 260.96 | 198.17 |
Income Tax Expense | 22.62 | 18.19 | 26.86 | 14.65 | 32.93 | 17.21 |
Earnings From Continuing Operations | 159.88 | 191.81 | 203.33 | 164.72 | 228.03 | 180.97 |
Minority Interest in Earnings | 0.37 | 0.14 | -0.63 | -0.49 | 8.3 | 12.03 |
Net Income | 160.26 | 191.95 | 202.71 | 164.23 | 236.34 | 193 |
Net Income to Common | 160.26 | 191.95 | 202.71 | 164.23 | 236.34 | 193 |
Net Income Growth | -17.17% | -5.31% | 23.43% | -30.51% | 22.45% | -34.71% |
Shares Outstanding (Basic) | 175 | 173 | 173 | 174 | 176 | 177 |
Shares Outstanding (Diluted) | 181 | 198 | 173 | 174 | 182 | 178 |
Shares Change (YoY) | 2.09% | 14.21% | -0.18% | -4.53% | 2.16% | -1.36% |
EPS (Basic) | 0.92 | 1.11 | 1.17 | 0.95 | 1.35 | 1.09 |
EPS (Diluted) | 0.88 | 0.97 | 1.17 | 0.95 | 1.30 | 1.08 |
EPS Growth | -18.87% | -17.09% | 23.65% | -27.21% | 19.86% | -33.80% |
Free Cash Flow | 105.88 | 17.06 | 254.69 | 136.14 | 196.45 | 85.46 |
Free Cash Flow Per Share | 0.58 | 0.09 | 1.47 | 0.78 | 1.08 | 0.48 |
Dividend Per Share | 0.350 | 0.650 | 0.769 | 0.385 | 0.538 | 0.385 |
Dividend Growth | -67.27% | -15.50% | 100.00% | -28.58% | 40.02% | -66.67% |
Gross Margin | 31.35% | 31.44% | 30.26% | 26.36% | 26.79% | 28.57% |
Operating Margin | 6.96% | 9.16% | 10.59% | 7.29% | 9.17% | 10.98% |
Profit Margin | 10.14% | 12.02% | 10.93% | 8.19% | 9.05% | 9.55% |
Free Cash Flow Margin | 6.70% | 1.07% | 13.73% | 6.79% | 7.52% | 4.23% |
EBITDA | 162 | 201.57 | 256.39 | 204.07 | 292.8 | 268.97 |
EBITDA Margin | 10.25% | 12.62% | 13.82% | 10.18% | 11.21% | 13.31% |
D&A For EBITDA | 51.93 | 55.37 | 59.96 | 57.93 | 53.3 | 47.14 |
EBIT | 110.08 | 146.2 | 196.44 | 146.14 | 239.5 | 221.83 |
EBIT Margin | 6.96% | 9.16% | 10.59% | 7.29% | 9.17% | 10.98% |
Effective Tax Rate | 12.39% | 8.66% | 11.67% | 8.17% | 12.62% | 8.68% |
Revenue as Reported | 1,581 | 1,597 | 1,855 | 2,005 | 2,613 | 2,021 |
Advertising Expenses | - | 115.31 | 130.36 | 133.74 | 180.52 | 125.04 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.